Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.

Sethi S, Macoska J, Chen W, Sarkar FH.

Am J Transl Res. 2010 Oct 23;3(1):90-9.

3.

MicroRNAs and epithelial-mesenchymal transition in prostate cancer.

Sekhon K, Bucay N, Majid S, Dahiya R, Saini S.

Oncotarget. 2016 Oct 11;7(41):67597-67611. doi: 10.18632/oncotarget.11708. Review.

5.

The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.

Ganguly SS, Li X, Miranti CK.

Front Oncol. 2014 Dec 15;4:364. doi: 10.3389/fonc.2014.00364. eCollection 2014. Review.

6.

Cellular Plasticity in Prostate Cancer Bone Metastasis.

Jadaan DY, Jadaan MM, McCabe JP.

Prostate Cancer. 2015;2015:651580. doi: 10.1155/2015/651580. Epub 2015 Jun 3. Review.

7.

Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.

Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS.

Mol Cancer. 2017 Jan 30;16(1):10. doi: 10.1186/s12943-016-0577-4. Review.

8.

Clinical significance of epithelial-mesenchymal transition.

Steinestel K, Eder S, Schrader AJ, Steinestel J.

Clin Transl Med. 2014 Jul 2;3:17. doi: 10.1186/2001-1326-3-17. eCollection 2014. Review.

9.

Molecular alterations that drive breast cancer metastasis to bone.

Ottewell PD, O'Donnell L, Holen I.

Bonekey Rep. 2015 Mar 18;4:643. doi: 10.1038/bonekey.2015.10. eCollection 2015. Review.

10.

Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.

Heery R, Finn SP, Cuffe S, Gray SG.

Cancers (Basel). 2017 Apr 21;9(4). pii: E38. doi: 10.3390/cancers9040038. Review.

11.

Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.

Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, Onuchic JN, Levine H.

Front Oncol. 2015 Jul 20;5:155. doi: 10.3389/fonc.2015.00155. eCollection 2015. Review.

12.

Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.

Chockley PJ, Keshamouni VG.

J Immunol. 2016 Aug 1;197(3):691-8. doi: 10.4049/jimmunol.1600458. Review.

PMID:
27431984
13.

Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT.

Zoni E, van der Pluijm G, Gray PC, Kruithof-de Julio M.

J Oncol. 2015;2015:198967. doi: 10.1155/2015/198967. Epub 2015 Mar 25. Review.

14.

P-Cadherin Linking Breast Cancer Stem Cells and Invasion: A Promising Marker to Identify an "Intermediate/Metastable" EMT State.

Ribeiro AS, Paredes J.

Front Oncol. 2015 Jan 5;4:371. doi: 10.3389/fonc.2014.00371. eCollection 2014. Review.

15.

Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5.

Kim S, Lee JW.

Genomics Inform. 2014 Mar;12(1):12-20. doi: 10.5808/GI.2014.12.1.12. Epub 2014 Mar 31. Review.

16.

Epithelial-mesenchymal transition in tumor metastasis.

Yeung KT, Yang J.

Mol Oncol. 2017 Jan;11(1):28-39. doi: 10.1002/1878-0261.12017. Epub 2016 Dec 9. Review.

17.

EMT in Breast Carcinoma-A Review.

Felipe Lima J, Nofech-Mozes S, Bayani J, Bartlett JM.

J Clin Med. 2016 Jul 14;5(7). pii: E65. doi: 10.3390/jcm5070065. Review.

18.

Role of Glycans in Cancer Cells Undergoing Epithelial-Mesenchymal Transition.

Li X, Wang X, Tan Z, Chen S, Guan F.

Front Oncol. 2016 Feb 17;6:33. doi: 10.3389/fonc.2016.00033. eCollection 2016. Review.

19.

Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition.

Espinoza I, Pochampally R, Xing F, Watabe K, Miele L.

Onco Targets Ther. 2013 Sep 6;6:1249-59. doi: 10.2147/OTT.S36162. Review.

20.

TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression.

Lin SJ, Yang DR, Li G, Chang C.

Front Endocrinol (Lausanne). 2015 May 27;6:78. doi: 10.3389/fendo.2015.00078. eCollection 2015. Review.

Supplemental Content

Support Center